BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33155059)

  • 1. Novel in vitro assays to detect circulating permeability factor(s) in idiopathic focal segmental glomerulosclerosis.
    den Braanker DJW; Maas RJ; Deegens JK; Yanginlar C; Wetzels JFM; van der Vlag J; Nijenhuis T
    Nephrol Dial Transplant; 2021 Jan; 36(2):247-256. PubMed ID: 33155059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary Focal Segmental Glomerulosclerosis Plasmas Increase Lipid Droplet Formation and Perilipin-2 Expression in Human Podocytes.
    den Braanker DJW; Maas RJH; van Mierlo G; Parr NMJ; Bakker-van Bebber M; Deegens JKJ; Jansen PWTC; Gloerich J; Willemsen B; Dijkman HB; van Gool AJ; Wetzels JFM; Rinschen MM; Vermeulen M; Nijenhuis T; van der Vlag J
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel mouse strains to study circulating permeability factor(s) in primary focal segmental glomerulosclerosis.
    den Braanker D; Maas R; Parr N; Deegens J; Smeets B; Wetzels J; van der Vlag J; Nijenhuis T
    PLoS One; 2022; 17(9):e0274959. PubMed ID: 36137166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel unbiased assay for circulating podocyte-toxic factors associated with recurrent focal segmental glomerulosclerosis.
    Kachurina N; Chung CF; Benderoff E; Babayeva S; Bitzan M; Goodyer P; Kitzler T; Matar D; Cybulsky AV; Alachkar N; Torban E
    Am J Physiol Renal Physiol; 2016 May; 310(10):F1148-56. PubMed ID: 26719363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis.
    McCarthy ET; Sharma M; Savin VJ
    Clin J Am Soc Nephrol; 2010 Nov; 5(11):2115-21. PubMed ID: 20966123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of glomerular and podocyte-specific genes and pathways activated by sera of patients with focal segmental glomerulosclerosis.
    Otalora L; Chavez E; Watford D; Tueros L; Correa M; Nair V; Ruiz P; Wahl P; Eddy S; Martini S; Kretzler M; Burke GW; Fornoni A; Merscher S
    PLoS One; 2019; 14(10):e0222948. PubMed ID: 31581251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Permeability Factors in Focal Segmental Glomerulosclerosis:
    Veissi ST; Smeets B; van Wijk JAE; Classens R; van der Velden TJAM; Jeronimus-Klaasen A; Veltkamp F; Mak-Nienhuis EM; Morello W; Montini G; Bouts AHM; van den Heuvel LPWJ; Schreuder MF
    Kidney Int Rep; 2022 Dec; 7(12):2691-2703. PubMed ID: 36506233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel diagnostic and therapeutic techniques reveal changed metabolic profiles in recurrent focal segmental glomerulosclerosis.
    Müller-Deile J; Sarau G; Kotb AM; Jaremenko C; Rolle-Kampczyk UE; Daniel C; Kalkhof S; Christiansen SH; Schiffer M
    Sci Rep; 2021 Feb; 11(1):4577. PubMed ID: 33633212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteinuria in focal segmental glomerulosclerosis: role of circulating factors and therapeutic approach.
    Moriconi L; Lenti C; Puccini R; Pasquariello A; Rindi P; Batini V; Carraro M; Zennaro C
    Ren Fail; 2001; 23(3-4):533-41. PubMed ID: 11499567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating CASK is associated with recurrent focal segmental glomerulosclerosis after transplantation.
    Beaudreuil S; Zhang X; Herr F; Harper F; Candelier JJ; Fan Y; Yeter H; Dudreuilh C; Lecru L; Vazquez A; Charpentier B; Lorenzo HK; Durrbach A
    PLoS One; 2019; 14(7):e0219353. PubMed ID: 31356645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma from a case of recurrent idiopathic FSGS perturbs non-muscle myosin IIA (MYH9 protein) in human podocytes.
    Babayeva S; Miller M; Zilber Y; El Kares R; Bernard C; Bitzan M; Goodyer P; Torban E
    Pediatr Nephrol; 2011 Jul; 26(7):1071-81. PubMed ID: 21380797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNFα pathway blockade ameliorates toxic effects of FSGS plasma on podocyte cytoskeleton and β3 integrin activation.
    Bitzan M; Babayeva S; Vasudevan A; Goodyer P; Torban E
    Pediatr Nephrol; 2012 Dec; 27(12):2217-26. PubMed ID: 22538781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma microRNA-186 and proteinuria in focal segmental glomerulosclerosis.
    Zhang C; Zhang W; Chen HM; Liu C; Wu J; Shi S; Liu ZH
    Am J Kidney Dis; 2015 Feb; 65(2):223-32. PubMed ID: 25218681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring suPAR levels in post-kidney transplant focal segmental glomerulosclerosis treated with therapeutic plasma exchange and rituximab.
    Alachkar N; Li J; Matar D; Vujjini V; Alasfar S; Tracy M; Reiser J; Wei C
    BMC Nephrol; 2018 Dec; 19(1):361. PubMed ID: 30558559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmapheresis in the treatment of steroid-resistant focal segmental glomerulosclerosis in native kidneys.
    Feld SM; Figueroa P; Savin V; Nast CC; Sharma R; Sharma M; Hirschberg R; Adler SG
    Am J Kidney Dis; 1998 Aug; 32(2):230-7. PubMed ID: 9708606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children.
    Dall'Amico R; Ghiggeri G; Carraro M; Artero M; Ghio L; Zamorani E; Zennaro C; Basile G; Montini G; Rivabella L; Cardillo M; Scalamogna M; Ginevri F
    Am J Kidney Dis; 1999 Dec; 34(6):1048-55. PubMed ID: 10585314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of plasma fractions from patients with focal and segmental glomerulosclerosis on rat proteinuria.
    Le Berre L; Godfrin Y; Lafond-Puyet L; Perretto S; Le Carrer D; Bouhours JF; Soulillou JP; Dantal J
    Kidney Int; 2000 Dec; 58(6):2502-11. PubMed ID: 11115084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LDL-apheresis-induced remission of focal segmental glomerulosclerosis recurrence in pediatric renal transplant recipients.
    Shah L; Hooper DK; Okamura D; Wallace D; Moodalbail D; Gluck C; Koziell A; Zaritsky JJ
    Pediatr Nephrol; 2019 Nov; 34(11):2343-2350. PubMed ID: 31250206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on Recurrent Focal Segmental Glomerulosclerosis in Kidney Transplantation.
    Shoji J; Mii A; Terasaki M; Shimizu A
    Nephron; 2020; 144 Suppl 1():65-70. PubMed ID: 33260184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin.
    Bertelli R; Ginevri F; Caridi G; Dagnino M; Sandrini S; Di Duca M; Emma F; Sanna-Cherchi S; Scolari F; Neri TM; Murer L; Massella L; Basile G; Rizzoni G; Perfumo F; Ghiggeri GM
    Am J Kidney Dis; 2003 Jun; 41(6):1314-21. PubMed ID: 12776285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.